Company · CIK 0001275187 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq
ANGIODYNAMICS INC · ANGO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2016 AForm 4 → | Jul 29, 4:44 pm EDT | Kevin J GouldDirector | 5,063 | — | — | 32,088 | — | plan? |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:41 pm EDT | Steve LaPorteDirector | 5,063 | — | — | 34,201 | — | plan? |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:37 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 3,447 | — | — | 31,280 | — | plan? |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:30 pm EDT | Howard W DonnellyDirector | 5,063 | — | — | 42,144 | — | plan? |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:27 pm EDT | Jeffrey GoldDirector | 5,063 | — | — | 49,679 | — | plan? |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:25 pm EDT | Wesley JohnsonDirector | 5,063 | — | — | 38,998 | — | plan? |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:21 pm EDT | Dennis S MetenyDirector | 5,063 | — | — | 58,793 | — | plan? |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:18 pm EDT | James C ClemmerPresident and CEO, Director | 21,191 | — | — | 71,191 | — | plan? |
| Jul 25, 2016 FForm 4 → | Jul 27, 5:13 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 439 | $16.49 | $7,239 | 27,833 | — | plan? |
| Jul 22, 2016 FForm 4 → | Jul 26, 6:19 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 399 | $16.52 | $6,591 | 28,272 | — | plan? |
| Jul 15, 2016 FMForm 4 → | Jul 18, 8:16 pm EDT | Howard W DonnellyDirector | 21,844 | $14.60 | $318,953 | 37,081 | — | plan? |
| Jul 15, 2016 FMForm 4 → | Jul 18, 8:14 pm EDT | Wesley JohnsonDirector | 21,844 | $14.60 | $318,953 | 33,935 | — | plan? |
| Jul 13, 2016 FMForm 4 → | Jul 15, 7:25 pm EDT | Steve LaPorteDirector | 22,005 | $14.49 | $318,960 | 29,138 | — | plan? |
| Jul 11, 2016 FMForm 4 → | Aug 18, 9:15 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 6,274 | $14.48 | $24,587 | 33,661 | — | plan? late |
| May 6, 2016 SForm 4 → | May 9, 4:05 pm EDT | Charles R GreinerVP - Global Franchise | 3,508 | $12.31 | $43,183 | 20,910 | −14.4% | plan? |
| Apr 25, 2016 FForm 4 → | Apr 25, 6:59 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 1,358 | $12.23 | $16,608 | 28,671 | — | plan? |
| Apr 21, 2016 SForm 4 → | Apr 25, 6:59 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 12,940 | $12.30 | $159,184 | 30,029 | −30.1% | plan? |
| Apr 4, 2016 AForm 4 → | Apr 5, 4:06 pm EDT | James C ClemmerPresident and CEO, Director | 50,000 | — | — | 50,000 | — | plan? |
| Sep 10, 2015 FForm 4 → | Sep 11, 8:39 pm EDT | John SotoSVP and CCO | 816 | $14.51 | $11,840 | 22,452 | — | plan? |
| Sep 8, 2015 FForm 4 → | Sep 11, 8:36 pm EDT | Joseph DevivoPresident and CEO, Director | 2,320 | $14.52 | $33,686 | 198,451 | — | plan? late |
| Aug 6, 2015 FForm 4 → | Aug 7, 4:51 pm EDT | John SotoSVP and CCO | 492 | $15.91 | $7,828 | 23,268 | — | plan? |
| Aug 6, 2015 FForm 4 → | Aug 7, 4:49 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 485 | $15.91 | $7,716 | 42,969 | — | plan? |
| Aug 6, 2015 FForm 4 → | Aug 7, 4:47 pm EDT | Charles R GreinerVP - Global Franchise | 465 | $15.91 | $7,398 | 24,418 | — | plan? |
| Aug 6, 2015 FForm 4 → | Aug 7, 4:45 pm EDT | Stark RichardSVP, GM - Oncology | 477 | $15.91 | $7,589 | 30,528 | — | plan? |
| Aug 6, 2015 FForm 4 → | Aug 7, 4:44 pm EDT | Mark T FrostEVP and CFO | 797 | $15.91 | $12,680 | 38,389 | — | plan? |
| Aug 6, 2015 FForm 4 → | Aug 7, 4:42 pm EDT | Joseph DevivoPresident and CEO, Director | 1,660 | $15.91 | $26,411 | 200,771 | — | plan? |
| Aug 5, 2015 FMForm 4 → | Aug 7, 4:39 pm EDT | Dennis S MetenyDirector | 11,795 | $15.54 | $183,239 | 53,730 | — | plan? |
| Aug 5, 2015 FMForm 4 → | Aug 6, 2:05 pm EDT | Wesley JohnsonDirector | 11,795 | $15.54 | $183,239 | 31,779 | — | plan? |
| Aug 5, 2015 FMForm 4 → | Aug 6, 1:58 pm EDT | Jeffrey GoldDirector | 11,795 | $15.54 | $183,239 | 44,616 | — | plan? |
| Aug 3, 2015 FForm 4 → | Aug 5, 9:57 pm EDT | Stark RichardSVP, GM - Oncology | 1,652 | $15.54 | $25,672 | 31,005 | — | plan? |
| Aug 3, 2015 FForm 4 → | Aug 5, 9:57 pm EDT | Joseph DevivoPresident and CEO | 2,014 | $15.54 | $31,298 | 202,431 | — | plan? |
| Aug 3, 2015 FMForm 4 → | Aug 5, 9:48 pm EDT | Charles R GreinerVP - Global Franchise | 29,087 | $15.54 | $451,929 | 24,883 | — | plan? |
| Aug 3, 2015 FMForm 4 → | Aug 5, 9:47 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 12,786 | $15.54 | $198,660 | 43,454 | — | plan? |
| Jul 27, 2015 FForm 4 → | Jul 29, 8:57 pm EDT | Mark T FrostEVP and CFO | 696 | $15.63 | $10,878 | 39,186 | — | plan? |
| Jul 27, 2015 FForm 4 → | Jul 29, 8:56 pm EDT | Joseph DevivoPresident and CEO, Director | 2,796 | $15.63 | $43,701 | 204,445 | — | plan? |
| Jul 27, 2015 FForm 4 → | Jul 29, 8:55 pm EDT | John SotoSVP and CCO | 566 | $15.63 | $8,847 | 23,760 | — | plan? |
| Jul 27, 2015 FForm 4 → | Jul 29, 8:54 pm EDT | Charles R GreinerVP - Global Franchise | 411 | $15.63 | $6,424 | 25,770 | — | plan? |
| Jul 27, 2015 FForm 4 → | Jul 29, 8:53 pm EDT | Stark RichardSVP, GM - Oncology | 421 | $15.63 | $6,580 | 32,567 | — | plan? |
| Jul 27, 2015 FForm 4 → | Jul 29, 8:51 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 428 | $15.63 | $6,690 | 44,640 | — | plan? |
| Jul 22, 2015 AFMForm 4 → | Aug 6, 1:54 pm EDT | Steve LaPorteDirector | 17,061 | $15.54 | $183,239 | 27,143 | — | plan? late |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:35 pm EDT | Jeffrey GoldDirector | 5,266 | — | — | 44,411 | — | plan? |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:34 pm EDT | Kevin J GouldDirector | 5,266 | — | — | 27,025 | — | plan? |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:34 pm EDT | Wesley JohnsonDirector | 5,266 | — | — | 31,574 | — | plan? |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:33 pm EDT | Charles R GreinerVP - Global Franchise | 4,126 | — | — | 26,181 | — | plan? |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:32 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 4,303 | — | — | 45,068 | — | plan? |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:31 pm EDT | John SotoEVP and CCO | 5,428 | — | — | 24,326 | — | plan? |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:30 pm EDT | Stark RichardSVP, GM - Oncology | 4,287 | — | — | 32,988 | — | plan? |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:28 pm EDT | Mark T FrostEVP and CFO | 5,969 | — | — | 39,882 | — | plan? |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:28 pm EDT | Joseph DevivoPresident and CEO, Director | 28,061 | — | — | 207,241 | — | plan? |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:27 pm EDT | Dennis S MetenyDirector | 5,266 | — | — | 53,525 | — | plan? |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:26 pm EDT | David F BurgstahlerDirector | 5,266 | — | — | 18,925 | — | plan? |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:26 pm EDT | Howard W DonnellyDirector | 5,266 | — | — | 34,925 | — | plan? |
| Jul 16, 2015 MForm 4 → | Jul 17, 7:02 pm EDT | Howard W DonnellyDirector | 6,000 | $15.27 | $91,620 | 29,659 | — | plan? |
| Jun 8, 2015 MForm 4 → | Jun 10, 5:47 pm EDT | Wesley JohnsonDirector | 4,649 | $16.55 | $76,941 | 26,308 | — | plan? |
| Apr 24, 2015 AForm 4 → | Apr 28, 6:43 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 15,000 | — | — | 40,765 | — | plan? |
| Feb 13, 2015 SForm 4 → | Feb 19, 4:20 pm EST | Stark RichardSVP, GM - Oncology | 18,100 | $18.53 | $335,393 | 28,701 | −38.7% | plan? late |
| Feb 13, 2015 MForm 4 → | Feb 19, 4:20 pm EST | Stark RichardSVP, GM - Oncology | 18,100 | $15.27 | $276,387 | 46,801 | — | plan? late |
| Jan 28, 2015 FForm 4 → | Jan 29, 7:59 pm EST | Stark RichardSVP, GM - Oncology | 419 | $19.42 | $8,137 | 28,701 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 MForm 4 → | Jul 24, 6:10 pm EDT | Laura PiccininiSVP International | 28,336 | — | — | 0 | — | |
| Jul 22, 2026 MForm 4 → | Jul 24, 6:10 pm EDT | Warren Nighan Jr.SVP Quality and Regulatory | 20,052 | — | — | 0 | — | |
| Jul 22, 2026 MForm 4 → | Jul 24, 6:10 pm EDT | Stephen A TrowbridgeEVP and CFO | 57,381 | — | — | 0 | — | |
| Jul 22, 2026 MForm 4 → | Jul 24, 6:10 pm EDT | James C ClemmerPresident and CEO, Director | 184,361 | — | — | 0 | — | |
| Jul 22, 2026 MForm 4 → | Jul 24, 6:10 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 22,768 | — | — | 0 | — | |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Stephen A TrowbridgeEVP and CFO | 53,257 | — | — | 53,257 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Laura PiccininiSVP International | 19,860 | — | — | 19,860 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Warren Nighan Jr.SVP Quality and Regulatory | 17,966 | — | — | 17,966 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 16,081 | — | — | 16,081 | — | late |
| Jul 15, 2026 AForm 4 → | Jul 22, 8:06 pm EDT | Lawrence T WeissSVP, Chief Legal Officer | 21,288 | — | — | 21,288 | — | late |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:43 pm EDT | Robert Arthur SimpsonSVP/GM, Global Vascular | 24,622 | — | — | 9,496 | — | |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:41 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 24,469 | — | — | 9,437 | — | |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:38 pm EDT | Michael GreinerEVP and CFO | 36,235 | — | — | 13,975 | — | |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:36 pm EDT | James C ClemmerPresident and CEO, Director | 90,589 | — | — | 34,938 | — | |
| Jul 18, 2018 AForm 4 → | Jul 20, 9:34 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 18,355 | — | — | 7,079 | — | |
| Jul 12, 2018 MForm 4 → | Aug 22, 7:05 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 5,737 | — | — | 0 | — | late |
| Jul 6, 2018 MForm 4 → | Jul 10, 6:44 pm EDT | Jeffrey GoldDirector | 7,000 | — | — | 0 | — | |
| Jun 22, 2018 MForm 4 → | Jun 25, 4:20 pm EDT | Wesley JohnsonDirector | 14,000 | — | — | 0 | — | |
| Jun 21, 2018 MForm 4 → | Jun 25, 4:30 pm EDT | Dennis S MetenyDirector | 14,000 | — | — | 0 | — | |
| Jun 21, 2018 MForm 4 → | Jun 25, 4:26 pm EDT | Howard W DonnellyDirector | 6,650 | — | — | 0 | — | |
| Jun 21, 2018 MForm 4 → | Jun 25, 4:23 pm EDT | Jeffrey GoldDirector | 7,000 | — | — | 0 | — | |
| Nov 21, 2017 MForm 4 → | Nov 22, 1:48 pm EST | Howard W DonnellyDirector | 14,000 | — | — | 0 | — | |
| Nov 15, 2017 MForm 4 → | Nov 17, 4:08 pm EST | Stark RichardSVP, GM - Oncology | 27,409 | — | — | 0 | — | |
| Sep 12, 2017 MForm 4 → | Sep 14, 3:24 pm EDT | Kevin J GouldDirector | 39,000 | — | — | 0 | — | |
| Jul 26, 2017 AForm 4 → | Jul 28, 5:38 pm EDT | James C ClemmerPresident and CEO, Director | 121,811 | — | — | 44,184 | — | |
| Jul 26, 2017 AForm 4 → | Jul 28, 5:35 pm EDT | Chad Thomas CampbellSVP/GM, Vascular Access | 18,428 | — | — | 6,684 | — | |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:15 pm EDT | Stark RichardSVP, GM - Oncology | 20,114 | — | — | 7,296 | — | |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:12 pm EDT | Robert Arthur SimpsonSVP/GM, Global Vascular | 20,614 | — | — | 7,477 | — | |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:08 pm EDT | Michael GreinerEVP and CFO | 34,149 | — | — | 12,387 | — | |
| Jul 26, 2017 AForm 4 → | Jul 28, 3:05 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 20,427 | — | — | 7,409 | — | |
| Jul 25, 2017 MForm 4 → | Aug 8, 5:48 pm EDT | Wesley JohnsonDirector | 14,000 | — | — | 0 | — | late |
| Jul 25, 2017 MForm 4 → | Aug 8, 5:44 pm EDT | Dennis S MetenyDirector | 14,000 | — | — | 0 | — | late |
| Jul 25, 2017 MForm 4 → | Jul 28, 3:47 pm EDT | Jeffrey GoldDirector | 14,000 | — | — | 0 | — | late |
| Jun 19, 2017 MForm 4 → | Jun 21, 9:42 pm EDT | Howard W DonnellyDirector | 14,000 | — | — | 0 | — | |
| Jan 13, 2017 MForm 4 → | Jan 17, 2:34 pm EST | Steve LaPorteDirector | 14,000 | — | — | 0 | — | |
| Nov 7, 2016 AForm 4 → | Nov 9, 4:58 pm EST | Jan Stern ReedDirector | 25,000 | — | — | 25,000 | — | |
| Nov 7, 2016 AForm 4 → | Nov 9, 4:56 pm EST | Eileen O'Shea AuenDirector | 25,000 | — | — | 25,000 | — | |
| Aug 31, 2016 DForm 4 → | Sep 6, 6:54 pm EDT | Dennis S MetenyDirector | 12,000 | — | — | 0 | — | late |
| Aug 31, 2016 DForm 4 → | Sep 6, 6:51 pm EDT | Jeffrey GoldDirector | 12,000 | — | — | 0 | — | late |
| Aug 18, 2016 AForm 4 → | Aug 22, 6:52 pm EDT | Michael GreinerEVP and CFO | 120,000 | — | — | 20,000 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:48 pm EDT | David F BurgstahlerDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:44 pm EDT | Kevin J GouldDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:41 pm EDT | Steve LaPorteDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:37 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 19,036 | — | — | 6,984 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:30 pm EDT | Howard W DonnellyDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:27 pm EDT | Jeffrey GoldDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:25 pm EDT | Wesley JohnsonDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:21 pm EDT | Dennis S MetenyDirector | 5,945 | — | — | 5,945 | — | |
| Jul 27, 2016 AForm 4 → | Jul 29, 4:18 pm EDT | James C ClemmerPresident and CEO, Director | 74,642 | — | — | 74,642 | — | |
| Jul 15, 2016 MForm 4 → | Jul 18, 8:16 pm EDT | Howard W DonnellyDirector | 12,000 | — | — | 0 | — | |
| Jul 15, 2016 MForm 4 → | Jul 18, 8:14 pm EDT | Wesley JohnsonDirector | 12,000 | — | — | 0 | — | |
| Jul 13, 2016 MForm 4 → | Jul 15, 7:25 pm EDT | Steve LaPorteDirector | 12,000 | — | — | 0 | — | |
| Jul 11, 2016 MForm 4 → | Aug 18, 9:15 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 7,151 | — | — | 0 | — | late |
| Apr 4, 2016 AForm 4 → | Apr 5, 4:06 pm EDT | James C ClemmerPresident and CEO, Director | 450,000 | — | — | 250,000 | — | |
| Aug 5, 2015 MForm 4 → | Aug 7, 4:39 pm EDT | Dennis S MetenyDirector | 6,000 | — | — | 0 | — | |
| Aug 5, 2015 MForm 4 → | Aug 6, 2:05 pm EDT | Wesley JohnsonDirector | 6,000 | — | — | 0 | — | |
| Aug 5, 2015 MForm 4 → | Aug 6, 1:58 pm EDT | Jeffrey GoldDirector | 6,000 | — | — | 0 | — | |
| Aug 5, 2015 MForm 4 → | Aug 5, 9:48 pm EDT | Charles R GreinerVP - Global Franchise | 14,100 | — | — | 0 | — | |
| Aug 5, 2015 MForm 4 → | Aug 5, 9:47 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 5,800 | — | — | 0 | — | |
| Jul 22, 2015 AMForm 4 → | Aug 6, 1:54 pm EDT | Steve LaPorteDirector | 12,022 | — | — | 0 | — | late |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:35 pm EDT | Jeffrey GoldDirector | 6,022 | — | — | 6,022 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:34 pm EDT | Kevin J GouldDirector | 6,022 | — | — | 6,022 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:34 pm EDT | Wesley JohnsonDirector | 6,022 | — | — | 6,022 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:33 pm EDT | Charles R GreinerVP - Global Franchise | 19,654 | — | — | 5,501 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:32 pm EDT | Stephen A TrowbridgeSVP and General Counsel | 20,495 | — | — | 5,737 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:31 pm EDT | John SotoEVP and CCO | 25,854 | — | — | 7,237 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:30 pm EDT | Stark RichardSVP, GM - Oncology | 20,420 | — | — | 5,716 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:28 pm EDT | Mark T FrostEVP and CFO | 28,431 | — | — | 7,958 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:28 pm EDT | Joseph DevivoPresident and CEO, Director | 133,665 | — | — | 37,414 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:27 pm EDT | Dennis S MetenyDirector | 6,022 | — | — | 6,022 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:26 pm EDT | David F BurgstahlerDirector | 6,022 | — | — | 6,022 | — | |
| Jul 22, 2015 AForm 4 → | Jul 24, 9:26 pm EDT | Howard W DonnellyDirector | 6,022 | — | — | 6,022 | — | |
| Jul 16, 2015 MForm 4 → | Jul 17, 7:02 pm EDT | Howard W DonnellyDirector | 6,000 | — | — | 0 | — | |
| Jun 8, 2015 MForm 4 → | Jun 10, 5:47 pm EDT | Wesley JohnsonDirector | 4,649 | — | — | 0 | — | |
| Feb 13, 2015 MForm 4 → | Feb 19, 4:20 pm EST | Stark RichardSVP, GM - Oncology | 18,100 | — | — | 0 | — | late |